CVS Specialty Pharmacy to be ‘core partner’ in TrumpRx fertility program

CVS Health (CVS) announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization drug to bring the price of the medicine down by 84%. The company said it anticipates the program will be available in January 2026. “Fertility medications often require special administration and high-touch expertise. We are proud to join the President to help make every step of the journey as simple as possible for families by providing nationwide access,” said Lucille Accetta, RPh, Senior Vice President and Chief Pharmacy Officer, CVS Health. “We are committed to being America’s most trusted health care company as we strive to continually improve affordability and access to medicine for families everywhere.